Hyperparathyroidism and Malnutrition with Severe Vitamin D Deficiency

被引:16
作者
Agarwal, Amit [1 ]
Gupta, Sushil Kumar [2 ]
Sukumar, Ranjith [1 ]
机构
[1] SGPGIMS, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] SGPGIMS, Dept Endocrinol, Lucknow 226014, Uttar Pradesh, India
关键词
MESSENGER-RIBONUCLEIC-ACID; CALCIUM-SENSING RECEPTOR; PARATHYROID CELL-PROLIFERATION; BONE-MINERAL DENSITY; MEN1; GENE-MUTATIONS; LOW DIETARY CALCIUM; HYPOVITAMINOSIS-D; HIGH PREVALENCE; D INSUFFICIENCY; SECONDARY HYPERPARATHYROIDISM;
D O I
10.1007/s00268-009-0044-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Vitamin D deficiency and its associated problems are common in developing Asian countries and countries of the Middle East. Various factors, including poor nutritional status and other compounding factors such as dietary, cultural, ethnic, and environmental factors, play a major role in contributing to the poor calcium and vitamin D homeostasis. Vitamin D deficiency is thought to exacerbate signs and symptoms of hyperparathyroidism (HPT). In this overview, we present evidence of the impact of vitamin D and calcium deficiency on primary HPT (PHPT). Methods We performed an evidence-based review of articles published in the English language between January 1960 and June 2008. Results Level IV evidence suggests widespread calcium and vitamin D deficiency in developing countries (issue 1). Limited level IV evidence suggests malnutrition as a primary cause of calcium and vitamin D deficiency (issue 2). Level IV evidence suggests that calcium and vitamin deficiencies cause secondary HPT and possibly PHPT as well (issues 3 and 4). A literature search revealed only six studies that correlated vitamin D levels with clinical, biochemical, and pathologic features of PHPT (issue 5). These studies provide level IV evidence suggesting that vitamin D deficiency causes some specific clinical features of PHPT as well as exacerbating other features of the disease. Conclusions In the developing countries, which have severe vitamin D and calcium deficient population, PHPT patients present with advanced disease and particularly severe bone symptoms. There is presently only level IV evidence of vitamin D status affecting the clinical severity of PHPT.
引用
收藏
页码:2303 / 2313
页数:11
相关论文
共 109 条
[61]  
2-#
[62]   INFLUENCE OF CALCIUM AND 1,25-DIHYDROXYCHOLECALCIFEROL ON PROLIFERATION AND PROTO-ONCOGENE EXPRESSION IN PRIMARY CULTURES OF BOVINE PARATHYROID CELLS [J].
KREMER, R ;
BOLIVAR, I ;
GOLTZMAN, D ;
HENDY, GN .
ENDOCRINOLOGY, 1989, 125 (02) :935-941
[63]   Vitamin D status and nutrition in Europe and Asia [J].
Lips, P. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :620-625
[64]   Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications [J].
Lips, P .
ENDOCRINE REVIEWS, 2001, 22 (04) :477-501
[65]  
LOMINITZ E, 1966, J CLIN ENDOCR, V26, P309
[66]   Severe generalized bone pain and osteoporosis in a premenopausal black female:: Effect of vitamin D replacement [J].
Malabanan, AO ;
Turner, AK ;
Holick, MF .
JOURNAL OF CLINICAL DENSITOMETRY, 1998, 1 (02) :201-204
[67]   Vitamin D and bone mineral density status of healthy schoolchildren in northern India [J].
Marwaha, RK ;
Tandon, N ;
Reddy, DRH ;
Aggarwal, R ;
Singh, R ;
Sawhney, RC ;
Saluja, B ;
Game, MA ;
Singh, S .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (02) :477-482
[68]   Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption [J].
McKane, WR ;
Khosla, S ;
Egan, KS ;
Robins, SP ;
Burritt, MF ;
Riggs, BL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1699-1703
[69]   Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women [J].
Mezquita-Raya, P ;
Muñoz-Torres, M ;
Luna, JD ;
Luna, V ;
Lopez-Rodriguez, F ;
Torres-Vela, E ;
Escobar-Jiménez, F .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (08) :1408-1415
[70]   Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism [J].
Miedlich, S ;
Krohn, K ;
Lamesch, P ;
Müller, A ;
Paschke, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (01) :47-54